17 September 2019PatentsIain Armstrong

Immunotherapy patents: Why CAR-T is driving up patent activity

Immunotherapies are a hugely promising therapeutic area, in terms of both clinical benefits and potential market size. These treatments augment the body’s own immune response to improve its effectiveness in fighting diseases, particularly cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UK-India trade deal is ‘missed opportunity’, say industry bodies

SEPs now searchable on WIPO’s global patent database

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Cahill expands practice with three-partner team from King & Spalding

Apple must pay Optis $700m-the biggest patent award in UK history

Immunotherapy patents: Why CAR-T is driving up patent activity

More on this story

Editor's picks

Editor's picks

More articles